American Century Companies’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
Other funds holding BNGO
American Century Companies's BNGO Position: Q2 2023 in Review
American Century Companies sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 130 shares — an estimated $82.7K sold.
American Century Companies first reported a position in BNGO in Q3 2022 and held it in 3 quarters. The position peaked at $93.3K in Q4 2022. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.
- American Century Companies reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
- American Century Companies sold 130 Bionano Genomics shares in Q2 2023, an estimated $82.7K.
- American Century Companies first reported a position in Bionano Genomics in Q3 2022 and held it in 3 quarters.
- American Century Companies's Bionano Genomics position peaked at $93.3K in Q4 2022.
- 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.
Based on American Century Companies's 13F filing for Q2 2023, filed 14 Aug 2023.